Mouse ID | Treatment | Primary tumor volume(mm3) | Lesions outside of primary site (#) | Total # extraovarian lesions |
---|---|---|---|---|
201 | cisplatin | 195.7 | Â | 0 |
203 | cisplatin | 738.2 | Â | 0 |
204 | cisplatin | 70.3 | Â | 0 |
205 | cisplatin | 287.3 | Â | 0 |
207 | cisplatin | 208.9 | back/subQ (1) | 1 |
211 | cisplatin | 25.9 | back/subQ (1) | 1 |
214 | cisplatin | 51.2 | Â | 0 |
217 | cisplatin | NR | mouse died | Â |
229 | cisplatin | NT | Â | 0 |
234 | cisplatin | 93.3 | back/subQ (1) | 1 |
206 | vehicle | small | back/subQ (1) | 1 |
208 | vehicle | NR | mouse died | Â |
209 | vehicle | 172.6 | back/subQ (1) | 1 |
210 | vehicle | 118.3 | Â | 0 |
212 | vehicle | 11.7 | pelvis (1); back/subQ (1) | 2 |
221 | vehicle | 3.4 | Â | 0 |
222 | vehicle | 35.9 | cecum (1); | 1 |
224 | vehicle | 323.8 | diaphram (2); pelvis (1); bowel (1); back/subQ (1); mesentery (1) | 6 |
225 | vehicle | 184.4 | back/subQ (1) | 1 |
223 | vehicle | 212.0 | Â | 0 |
230 | vehicle | 234.0 | bowel (2) | 2 |
233 | vehicle | small | pelvis (1) | 1 |
202 | ML246 | NR | mouse died | Â |
213 | ML246 | 14.3 | Â | 0 |
215 | ML246 | NT | Â | 0 |
216 | ML246 | 140.7 | back/subQ (1) | 1 |
218 | ML246 | NR | mouse died | Â |
219 | ML246 | 114.6 | back/subQ (1) | 1 |
220 | ML246 | 917.4 | Â | 0 |
226 | ML246 | NT | back/subQ (2) | 2 |
227 | ML246 | NR | mouse died | Â |
228 | ML246 | NT | Â | 0 |
231 | ML246 | NT | Â | 0 |
232 | ML246 | 213.3 | Â | 0 |